North America Artificial Intelligence in Healthcare Diagnosis Market

Market Introduction

Artificial intelligence (AI) uses algorithms and software to perform specific tasks without human intervention and instructions. Artificial intelligence comprises the integration of several technologies, such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare to approximate human cognition and analyze complex medical and diagnostic imaging data. The artificial intelligence in the healthcare diagnosis market is driven by the ability of AI to improve patient outcomes, need to increase coordination between the healthcare workforce & patients.

North America Artificial Intelligence in Healthcare Diagnosis Strategic Insights

Strategic insights for the North America Artificial Intelligence in Healthcare Diagnosis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Artificial Intelligence in Healthcare Diagnosis Report Scope

North America Artificial Intelligence in Healthcare Diagnosis Regional Insights

The geographic scope of the North America Artificial Intelligence in Healthcare Diagnosis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America artificial intelligence in healthcare diagnosis marketis projectedto expected to grow from US$ 1,716.42 million in 2019 to US$ 32,009.61 million by 2027. This represents a CAGR of 44.3% from 2020 to 2027.The growth of the North America artificial intelligence in healthcare diagnosismarket is attributed to Rising Adoption of Artificial Intelligence (AI) in disease identification and diagnosis, and Increasing investment in AI healthcare startups. However, the lack of skilled ai workforce and ambiguous regulatory guidelines for medical softwarelimits the growth of market in this region. Countries in North America are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries has been affected badly. Due to growing coronavirus cases, many business related activities such as product launches and product promotion conferences has been postponed, leading to restraining the growth of the market.

Key Market Segments

Based on Diagnostic Tool, the North America artificial intelligence in healthcare diagnosis market is segmented into medical imaging tool, automated detection system, and others. In 2019, the medical imaging toolsegment held a larger share of the market. Whereas, automated detection systemsegment is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred towhile preparing the North America artificial intelligence in healthcare diagnosismarketreport are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.

General Electric Company, Koninklijke Philips N.V., Aidoc, Arterys Inc., Icometrix, IDx Technologies Inc., MaxQ AI Ltd., Caption Health, Inc., Zebra Medical Vision, Inc., Siemens Healthcare Private Limited

Reasons to buy the report

• To understand the North America artificial intelligence in healthcare diagnosis marketlandscape and identifymarket segments that are most likely to guarantee a strong return
• To stay ahead incomprehending the ever-changing competitive landscape of theNorth America artificial intelligence in healthcare diagnosis market
• To efficiently plan M&A and partnership dealsin the North America artificial intelligence in healthcare diagnosis marketby identifying market segments with the most promising probable sales
• To help takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segmentsinthe North America artificial intelligence in healthcare diagnosismarket
• To obtain market revenue forecast from 2019 to 2027 in various segmentsofthe North America artificial intelligence in healthcare diagnosis market

NORTH AMERICAARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKETSEGMENTATION

By Diagnostic Tool

·         Medical Imaging Tool

·         Automated Detection System

·         Others

By Application

·         Eye Care

·         Oncology

·         Radiology

·         Cardiovascular

·         Others

By Service

·         Tele-Consultation

·         Tele Monitoring

·         Others

By

End User

·         Hospitals and Clinics

·         Diagnostic Laboratory

·         Home Care

o      Doctors

o      Patients

By

Country

·         US

·         Canada

·         Mexico

CompanyProfiles

• General Electric Company
• Koninklijke Philips N.V.
• Aidoc, Arterys Inc.
• Icometrix, IDx Technologies Inc.
•  MaxQ AI Ltd.
• Caption Health, Inc.
• Zebra Medical Vision, Inc.
• Siemens Healthcare Private Limited